INRAE scientists have identified seven bacteria involved in the microbiota barrier effect, which prevents pathogenic bacteria ...

Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its ...

Infections caused by pathogenic microorganisms, including bacteria, viruses, fungi, and other eukaryotic microbes, seriously ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of ...

A pathogen is a living thing that causes disease. Viruses and bacteria can be pathogens, but there are also other types of pathogens. Every single living thing, even bacteria themselves ...

It reduces the quantity of pathogenic bacteria in infected organs, without damaging the host microbiota. It is capable of blocking the function of Mfd as a mutation factor, thereby reducing the ...

The findings, released Sunday and published in the journal mSphere, come amid rising concern over how warming seas may be ...

With the new approach, pathogenic or even antibiotic-resistant bacteria could be eliminated in patients' intestines prior to surgical interventions. This would be particularly important in the ...

On the one hand, we are dependent on the microorganisms because they are the ones that digest the food in our intestine. On the other hand, there are also numerous pathogens present among the bacteria ...

Researchers are combining vaccines with harmless bacteria that compete with intestinal pathogens for food. Studies on mice show that this combination is more effective than vaccination or treatment ...